Jill Broadfoot | Chief Financial Officer |
Sanjay Shukla | President and Chief Executive Officer |
Joel Beatty | Citi |
Good afternoon, ladies and gentlemen, and welcome to the aTyr Pharma's First Quarter 2019 Conference Call. At this time all participants are in a listen-only mode. Later we will conduct a question-and-answer session and instructions will be given at that time.
As a reminder to our audience, this conference is being recorded for replay purposes. It is now my pleasure to hand the conference over to Jill Broadfoot, aTyr's Chief Financial Officer.